Acro Biomedical Co annual revenue
2017
2018
2019
2019
2020
2021
2022
2023
2024
2025
Acro Biomedical Co Revenue Growth & History (ACBM)
Acro Biomedical Co reported $0 in revenue for fiscal 2025.
View full Acro Biomedical Co company overviewAcro Biomedical Co annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | −$658,500 | −100.00% |
| 2022 | 2022-12-31 | $658,500 | −$539,000 | −45.01% |
| 2021 | 2021-12-31 | $1.2M | $509,536 | +74.06% |
| 2020 | 2020-12-31 | $687,964 | $494,428 | +255.47% |
| 2019 · Dec 31 | 2019-12-31 | $193,536 | — | — |
| 2019 · Sep 30 | 2019-09-30 | $1.4M | −$6.7M | −83.11% |
| 2018 | 2018-09-30 | $8.0M | $7.5M | +1471.47% |
| 2017 | 2017-09-30 | $510,000 | — | — |
Acro Biomedical Co quarterly revenue
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | $0 | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q1 2025 | 2025-03-31 | $0 | $0 | — |
| Q4 2024 | 2024-12-31 | $0 | $0 | — |
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q2 2024 | 2024-06-30 | $0 | $0 | — |
| Q1 2024 | 2024-03-31 | $0 | $0 | — |
| Q4 2023 | 2023-12-31 | $0 | −$360,000 | −100.00% |
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q2 2023 | 2023-06-30 | $0 | $0 | — |
| Q1 2023 | 2023-03-31 | $0 | −$298,500 | −100.00% |
| Q4 2022 | 2022-12-31 | $360,000 | −$238,000 | −39.80% |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q2 2022 | 2022-06-30 | $0 | −$500,000 | −100.00% |
| Q1 2022 | 2022-03-31 | $298,500 | $199,000 | +200.00% |
| Q4 2021 | 2021-12-31 | $598,000 | $598,000 | — |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q2 2021 | 2021-06-30 | $500,000 | $500,000 | — |
| Q1 2021 | 2021-03-31 | $99,500 | −$588,464 | −85.54% |
| Q4 2020 | 2020-12-31 | $0 | −$193,536 | −100.00% |
| Q3 2020 | 2020-09-30 | $0 | $0 | — |
| Q2 2020 | 2020-06-30 | $0 | $0 | — |
| Q1 2020 | 2020-03-31 | $687,964 | $687,964 | — |
| Q4 2019 · Dec 31 | 2019-12-31 | $193,536 | −$1.2M | −85.71% |
| Q4 2019 | 2019-09-30 | $0 | −$2.4M | −100.00% |
| Q3 2019 | 2019-06-30 | $0 | −$2.2M | −100.00% |
| Q2 2019 | 2019-03-31 | $0 | −$2.0M | −100.00% |
| Q1 2019 | 2018-12-31 | $1.4M | −$91,000 | −6.30% |
| Q4 2018 | 2018-09-30 | $2.4M | — | — |
| Q3 2018 | 2018-06-30 | $2.2M | — | — |
| Q2 2018 | 2018-03-31 | $2.0M | — | — |
| Q1 2018 | 2017-12-31 | $1.4M | — | — |
Acro Biomedical Co revenue growth trends
Acro Biomedical Co's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Acro Biomedical Co source filings ↗